AVY
Avery Dennison Corporation NYSE Listed Apr 4, 1977$165.56
Mkt Cap $12.7B
52w Low $156.23
21.5% of range
52w High $199.54
50d MA $171.99
200d MA $174.83
P/E (TTM)
18.5x
EV/EBITDA
13.5x
P/B
5.6x
Debt/Equity
1.7x
ROE
30.7%
P/FCF
19.8x
RSI (14)
—
ATR (14)
—
Beta
1.00
50d MA
$171.99
200d MA
$174.83
Avg Volume
666.4K
Avery Dennison Corporation manufactures and markets pressure-sensitive materials and products in the United States, Europe, Asia, Latin America, and internationally. The company's Label and Graphic Materials segment offers pressure-sensitive label and packaging materials; and graphics and reflective products under the Fasson, JAC, Avery Dennison, and Mactac brands, as well as durable cast and reflective films. It provides its products to the home and personal care, beer and beverage, durables, pharmaceutical, wine and spirits, and food market segments; architectural, commercial sign, digital printing, and other related market segments; construction, automotive, and fleet transportation market segments, as well as traffic and safety applications; and sign shops, commercial printers, and designers. The company's Retail Branding and Information Solutions segment designs, manufactures, and sells brand embellishments, graphic tickets, tags and labels, and sustainable packaging solutions, as well as offers creative services; radio-frequency identification products; visibility and loss prevention solutions; price ticketing and marking solutions; care, content, and country of origin compliance solutions; and brand protection and security solutions. It serves retailers, brand owners, apparel manufacturers, distributors, and industrial customers. The company's Industrial and Healthcare Materials segment offers tapes; pressure-sensitive adhesive based materials and converted products; medical fasteners; and performance polymers under the Fasson, Avery Dennison, and Yongle brands. It serves automotive, electronics, building and construction, general industrial, personal care, and medical markets. The company was formerly known as Avery International Corporation and changed its name to Avery Dennison Corporation in 1990. Avery Dennison Corporation was founded in 1935 and is headquartered in Glendale, California.
8080 Norton Parkway · Mentor, OH 44060 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TNS | 2.41 | 2.47 | +2.5% | 166.49 | -1.5% | -2.1% | +0.6% | -0.5% | -1.6% | +0.9% | — |
| Feb 4, 2026 | TNS | 2.40 | 2.45 | +2.1% | 193.13 | +0.1% | -0.1% | -0.7% | -1.1% | +0.6% | +1.1% | — |
| Oct 22, 2025 | TNS | 2.33 | 2.37 | +1.7% | 179.04 | +2.5% | +4.0% | -2.5% | -0.6% | -0.7% | -1.7% | — |
| Jul 22, 2025 | TNS | 2.39 | 2.42 | +1.3% | 181.67 | +0.5% | -1.1% | -0.7% | -0.4% | -1.9% | -1.2% | — |
| Apr 23, 2025 | TNS | 2.32 | 2.30 | -0.9% | 170.25 | -0.7% | +2.0% | -1.7% | -0.3% | +0.9% | -0.4% | — |
| Jan 30, 2025 | TNS | 2.39 | 2.38 | -0.4% | 182.49 | +1.2% | +1.8% | -1.3% | -0.4% | +1.1% | -1.6% | — |
| Oct 23, 2024 | TNS | 2.33 | 2.33 | +0.0% | 207.65 | -2.2% | -1.3% | +1.1% | -0.1% | -0.4% | +0.8% | — |
| Jul 23, 2024 | TNS | 2.26 | 2.42 | +7.1% | 220.56 | -0.5% | -2.6% | -2.6% | +2.2% | -0.4% | +1.3% | — |
| Apr 24, 2024 | TNS | 2.15 | 2.29 | +6.5% | 212.42 | -0.3% | +2.2% | +0.9% | -0.3% | -0.5% | +0.3% | — |
| Jan 31, 2024 | TNS | 2.15 | 2.16 | +0.5% | 199.45 | +0.6% | +0.0% | -0.3% | -1.5% | +1.3% | +2.3% | — |
| Oct 25, 2023 | TNS | 2.10 | 2.10 | +0.0% | 168.33 | -1.6% | +1.5% | -0.2% | +1.2% | +0.8% | -0.1% | — |
| Jul 25, 2023 | TNS | 2.01 | 1.92 | -4.5% | 174.66 | -0.7% | +3.4% | +1.6% | +0.6% | -0.3% | +0.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Citigroup | Maintains | Neutral → Neutral | — | $162.95 | $163.33 | +0.2% | +0.6% | -0.5% | -1.6% | +0.9% | +2.9% |
| Apr 29 | Truist | Maintains | Buy → Buy | — | $166.49 | $163.99 | -1.5% | -2.1% | +0.6% | -0.5% | -1.6% | +0.9% |
| Apr 29 | JP Morgan | Maintains | Overweight → Overweight | — | $166.49 | $163.99 | -1.5% | -2.1% | +0.6% | -0.5% | -1.6% | +0.9% |
| Apr 15 | Truist | Maintains | Buy → Buy | — | $170.85 | $170.25 | -0.4% | -1.7% | -1.0% | +3.7% | -0.2% | -1.5% |
| Apr 14 | Citigroup | Maintains | Neutral → Neutral | — | $172.22 | $171.69 | -0.3% | -0.8% | -1.7% | -1.0% | +3.7% | -0.2% |
| Apr 10 | UBS | Maintains | Buy → Buy | — | $173.81 | $174.22 | +0.2% | -1.5% | +0.6% | -0.8% | -1.7% | -1.0% |
| Feb 9 | JP Morgan | Maintains | Overweight → Overweight | — | $191.51 | $190.73 | -0.4% | -1.1% | +0.6% | +1.1% | +1.4% | +0.1% |
| Feb 6 | BMO Capital | Maintains | Outperform → Outperform | — | $192.88 | $193.58 | +0.4% | -0.7% | -1.1% | +0.6% | +1.1% | +1.4% |
| Feb 6 | Citigroup | Maintains | Neutral → Neutral | — | $192.88 | $193.58 | +0.4% | -0.7% | -1.1% | +0.6% | +1.1% | +1.4% |
| Feb 5 | UBS | Maintains | Buy → Buy | — | $193.13 | $193.37 | +0.1% | -0.1% | -0.7% | -1.1% | +0.6% | +1.1% |
| Jan 6 | Citigroup | Maintains | Neutral → Neutral | — | $180.54 | $181.12 | +0.3% | +0.8% | -0.8% | +3.0% | +1.3% | -0.2% |
| Jan 6 | Truist | Maintains | Buy → Buy | — | $180.54 | $181.12 | +0.3% | +0.8% | -0.8% | +3.0% | +1.3% | -0.2% |
| Oct 28 | Argus | Upgrade | Hold → Buy | — | $180.47 | $182.01 | +0.9% | -0.7% | -1.7% | -0.2% | -0.6% | -0.4% |
| Oct 23 | JP Morgan | Upgrade | Neutral → Overweight | — | $179.04 | $183.53 | +2.5% | +4.0% | -2.5% | -0.6% | -0.7% | -1.7% |
| Oct 23 | UBS | Upgrade | Neutral → Buy | — | $179.04 | $183.53 | +2.5% | +4.0% | -2.5% | -0.6% | -0.7% | -1.7% |
| Oct 13 | Truist | Maintains | Buy → Buy | — | $158.67 | $159.05 | +0.2% | -0.7% | +1.7% | -0.3% | -0.2% | +0.1% |
| Oct 6 | UBS | Maintains | Neutral → Neutral | — | $163.44 | $162.69 | -0.5% | -0.4% | -0.8% | +0.4% | -0.7% | -1.3% |
| Sep 29 | Citigroup | Maintains | Neutral → Neutral | — | $160.75 | $161.13 | +0.2% | -0.2% | +1.1% | +0.2% | +0.1% | +0.5% |
| Jul 23 | BMO Capital | Maintains | Outperform → Outperform | — | $181.67 | $182.54 | +0.5% | -1.1% | -0.7% | -0.4% | -1.9% | -1.2% |
| Jul 23 | JP Morgan | Maintains | Neutral → Neutral | — | $181.67 | $182.54 | +0.5% | -1.1% | -0.7% | -0.4% | -1.9% | -1.2% |
| Jul 15 | Raymond James | Maintains | Outperform → Outperform | — | $180.45 | $180.98 | +0.3% | -1.8% | +0.6% | +1.5% | -1.2% | +0.2% |
| Jul 11 | Citigroup | Maintains | Neutral → Neutral | — | $184.63 | $182.70 | -1.0% | -1.3% | -1.0% | -1.8% | +0.6% | +1.5% |
| Jul 9 | BofA Securities | Maintains | Buy → Buy | — | $182.24 | $182.74 | +0.3% | +0.7% | +0.6% | -1.3% | -1.0% | -1.8% |
| Apr 25 | BMO Capital | Maintains | Outperform → Outperform | — | $173.62 | $172.87 | -0.4% | -1.7% | -0.3% | +0.9% | -0.4% | -1.0% |
| Apr 24 | Baird | Maintains | Outperform → Outperform | — | $170.25 | $169.00 | -0.7% | +2.0% | -1.7% | -0.3% | +0.9% | -0.4% |
| Apr 24 | Barclays | Maintains | Overweight → Overweight | — | $170.25 | $169.00 | -0.7% | +2.0% | -1.7% | -0.3% | +0.9% | -0.4% |
| Apr 24 | JP Morgan | Downgrade | Overweight → Neutral | — | $170.25 | $169.00 | -0.7% | +2.0% | -1.7% | -0.3% | +0.9% | -0.4% |
| Apr 24 | Truist | Maintains | Buy → Buy | — | $170.25 | $169.00 | -0.7% | +2.0% | -1.7% | -0.3% | +0.9% | -0.4% |
| Apr 22 | Truist | Maintains | Buy → Buy | — | $169.03 | $170.26 | +0.7% | +3.4% | -2.6% | +2.0% | -1.7% | -0.3% |
| Apr 22 | Raymond James | Maintains | Outperform → Outperform | — | $169.03 | $170.26 | +0.7% | +3.4% | -2.6% | +2.0% | -1.7% | -0.3% |
| Apr 7 | UBS | Maintains | Neutral → Neutral | — | $170.25 | $167.50 | -1.6% | -2.3% | -4.0% | +5.8% | -1.4% | +1.9% |
| Mar 21 | BMO Capital | Maintains | Outperform → Outperform | — | $177.05 | $175.24 | -1.0% | -1.4% | +1.4% | -0.7% | +1.3% | +0.0% |
| Feb 3 | Barclays | Maintains | Overweight → Overweight | — | $185.73 | $182.46 | -1.8% | -1.3% | -0.4% | +1.1% | -1.6% | -1.4% |
| Jan 31 | Truist | Maintains | Buy → Buy | — | $182.49 | $184.70 | +1.2% | +1.8% | -1.3% | -0.4% | +1.1% | -1.6% |
| Jan 31 | Raymond James | Maintains | Outperform → Outperform | — | $182.49 | $184.70 | +1.2% | +1.8% | -1.3% | -0.4% | +1.1% | -1.6% |
| Jan 31 | JP Morgan | Upgrade | Neutral → Overweight | — | $182.49 | $184.70 | +1.2% | +1.8% | -1.3% | -0.4% | +1.1% | -1.6% |
| Jan 10 | UBS | Maintains | Neutral → Neutral | — | $187.71 | $185.35 | -1.3% | -1.5% | +1.7% | +0.7% | +0.5% | +0.5% |
| Jan 6 | Citigroup | Maintains | Neutral → Neutral | — | $185.09 | $185.29 | +0.1% | +1.6% | -0.7% | +0.5% | -1.5% | +1.7% |
| Jan 6 | BofA Securities | Maintains | Buy → Buy | — | $185.09 | $185.29 | +0.1% | +1.6% | -0.7% | +0.5% | -1.5% | +1.7% |
| Jan 6 | Truist | Maintains | Buy → Buy | — | $185.09 | $185.29 | +0.1% | +1.6% | -0.7% | +0.5% | -1.5% | +1.7% |
| Oct 28 | Barclays | Maintains | Overweight → Overweight | — | $207.16 | $208.65 | +0.7% | -0.1% | -0.4% | +0.8% | -0.4% | -0.4% |
| Oct 24 | JP Morgan | Downgrade | Overweight → Neutral | — | $207.65 | $203.09 | -2.2% | -1.3% | +1.1% | -0.1% | -0.4% | +0.8% |
| Oct 24 | BMO Capital | Maintains | Outperform → Outperform | — | $207.65 | $203.09 | -2.2% | -1.3% | +1.1% | -0.1% | -0.4% | +0.8% |
| Oct 17 | BofA Securities | Upgrade | Underperform → Buy | — | $214.93 | $220.00 | +2.4% | +1.6% | -0.5% | -0.9% | -1.4% | -2.2% |
| Oct 2 | Citigroup | Maintains | Neutral → Neutral | — | $219.82 | $218.60 | -0.6% | -1.5% | -1.8% | +0.9% | -0.3% | +0.2% |
| Sep 19 | BMO Capital | Maintains | Outperform → Outperform | — | $209.36 | $212.83 | +1.7% | +3.1% | -1.9% | +1.9% | +1.3% | +0.2% |
| Jul 25 | UBS | Downgrade | Buy → Neutral | — | $214.79 | $210.00 | -2.2% | -2.6% | +2.2% | -0.4% | +1.3% | +0.5% |
| Jul 24 | Truist | Maintains | Buy → Buy | — | $220.56 | $219.52 | -0.5% | -2.6% | -2.6% | +2.2% | -0.4% | +1.3% |
| Jul 24 | BMO Capital | Maintains | Outperform → Outperform | — | $220.56 | $219.52 | -0.5% | -2.6% | -2.6% | +2.2% | -0.4% | +1.3% |
| Jul 9 | UBS | Maintains | Buy → Buy | — | $215.10 | $215.08 | -0.0% | -1.0% | +1.7% | +0.6% | +1.3% | -0.8% |
No insider trades available.
8-K
Avery Dennison Corp. -- 8-K Filing
Avery Dennison's forward-looking statements and financial targets carry inherent risks and uncertainties detailed in their 2025 Form 10-K filing.
Apr 28
8-K · 5.03
! Medium
Avery Dennison Corp. -- 8-K 5.03: Amendment to Articles / Bylaws
Avery Dennison changed its fiscal year end, which may affect future financial reporting schedules and investor comparisons of quarterly and annual results.
Feb 26
8-K
Avery Dennison Corp. -- 8-K Filing
Avery Dennison reported Q4 and full-year 2025 results with forward-looking guidance subject to market risks and uncertainties affecting investor confidence in future performance.
Feb 4
Data updated apr 24, 2026 8:06pm
· Source: massive.com